Investorideas.com - Investor Ideas Podcasts Now on #Spotify @Spotify - #CryptoCorner, #Cannabis #Potcasts, Stock Guru Daily Podcast for Investing Ideas and Sector Trends
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Tuesday, July 31, 2018
Investorideas.com - #Cannabisstocks: NanoSphere Health Sciences (CSE: NSHS) (OTC: NSHSF) Partners with Delta 9 for Canadian Expansion
Investorideas.com - #Cannabisstocks: NanoSphere Health Sciences (CSE: NSHS) (OTC: NSHSF) Partners with Delta 9 for Canadian Expansion
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Investorideas.com - #Cannabisstocks: Aphria (TSX: $APH.TO and US OTC: $APHQF) Secures $25 Million Loan from WFCU Credit Union
Investorideas.com - #Cannabisstocks: Aphria (TSX: $APH.TO and US OTC: $APHQF) Secures $25 Million Loan from WFCU Credit Union
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Investorideas.com - The Source Dispensaries Launch New Cannarillo Cannabis Cigars
Investorideas.com - The Source Dispensaries Launch New Cannarillo Cannabis Cigars
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Lexaria Bioscience (OTCQX: $LXRP; CSE: $LXX.C) and Hill Street Beverage Company Announce Definitive Agreement for #Cannabis-Infused #Beverages
Lexaria Bioscience (OTCQX: $LXRP; CSE: $LXX.C) and
Hill Street Beverage Company Announce Definitive Agreement for #Cannabis-Infused
#Beverages
KELOWNA, BC and TORONTO, July 31, 2018 - Lexaria
Bioscience Corp. (OTCQX: LXRP; CSE: LXX; the "Company" or
"Lexaria"), a drug delivery platform innovator, and Hill Street
Beverage Company Inc., (TSXV:BEER; "Hill Street") jointly announced
that they have signed a Definitive Agreement to license Lexaria's
DehydraTECHTM, on a semi-exclusive basis, for a term of five (5) years, to
produce a line of cannabis-infused alcohol-free beverages for Canadian
distribution, following regulatory approval. The Definitive Agreement is the
conclusion of the process begun following the announcement of the non-binding
letter of intent in April 2018. Terms of the Definitive Agreement were not
disclosed.
Read this in full at http://www.investorideas.com/news/2018/cannabis/07313OTCQXLXRP.asp
US$56,250 (CDN$ 73,497), representing a portion of the
compensation payable to Lexaria, shall be paid and satisfied in common shares
in the capital of Hill Street, at a purchase price of CDN$0.175, for an
aggregate of 419,982 common shares (the "Compensation Shares"). The
issuance of the Compensation Shares is subject to regulatory approval,
including without limitation, the approval of the TSX Venture Exchange.
Lexaria's beverage formulation adaptations use
patented technology to act quickly, but without adding any taste or odour,
thereby delivering predictable experiences that dissipate more quickly than
many other cannabinoid edible products. Lexaria has already lab-tested Hill
Street's alcohol-free red and white wines to formulate cannabinoid-fortified
wines, and such tests show virtually zero cannabis taste or odour.
Hill Street CEO, Terry Donnelly, stated, "Our
goal is to provide traditional beer and wine drinkers with great tasting
products that use cannabis to mimic the onset and duration of effect that has
historically come from alcohol, but without alcohol's toxicity and added
calories. While the early versions of our wines infused with Lexaria's process
have shown great promise, we are extremely excited about the progress Lexaria
continues to make with their infusion technologies. Lexaria has already
demonstrated its importance to our model as a key strategic partner in our
business, and this agreement secures our future together. As Hill Street's
progress into producing the world's finest alcohol-free and cannabis-infused
beverages continues, Lexaria has demonstrated that they will continue to
innovate and improve on their process. This will help to ensure Hill Street is
always at the forefront of producing world-class wine, beer and other adult
format beverages."
Chris Bunka, CEO of Lexaria stated, "Hill
Street's award-winning and great-tasting wines and beers need an odourless and
tasteless infusion process like our powerful DehydraTECHTM platform to ensure
they will remain that way after the inclusion of cannabis. Our proven ability
to render full spectrum cannabis and hemp oil into a water-soluble ingredient
with no impact on the taste and smell of complex beverages like wine enables
Hill Street to produce adult format beverages that will give consumers the
recreational experience of cannabis, while enjoying tastes and experiences
consistent with consuming traditional wine, beer and other adult format
beverages."
About Hill Street Beverage Company Inc. (TSXV:BEER)
Founded in 2008, Hill Street Beverage Company is the
world's most award-winning company exclusively focused on alcohol-free beer,
wines, and adult format beverages. Hill Street products include: Vin(Zero)
wines, Vintense wines, Hill Street Craft Brewed Lager, and Designated Draft
beer. Hill Street's award-winning products have won the Retail Council of
Canada's Grand Prix, and numerous medals and accolades including three Gold,
two Silver, and two Bronze Medals at the U.S. Open Beer Championships, and a
prestigious Double Gold Medal at the San Francisco International Wine
Challenge. As a result of the Royal Assent of Canada's Bill C-45, legislation
to allow the sale of cannabis-infused beverages is to occur by October 17,
2019. Hill Street is currently applying for appropriate licenses to permit the
production and sale of cannabis infused beverages in Canada, with the view of
having infused products available for sale once the regulations permit. www.hillstreetbeverages.com
About Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX)
Lexaria Bioscience Corp. licenses disruptive patented
delivery technology that promotes healthier ingestion methods, lower overall
dosing and higher effectiveness of lipophilic active molecules. Lexaria has
multiple patents pending in over 40 countries around the world and has patents
granted in the USA and in Australia for utilization of its DehydraTECHTM
delivery technology. Lexaria's technology provides increases in intestinal
absorption rates; more rapid delivery to the bloodstream; and important
taste-masking benefits, for orally administered bioactive molecules including
cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs),
nicotine and other molecules.
FORWARD-LOOKING STATEMENTS
This release includes forward-looking statements.
Statements which are not historical facts are forward-looking statements. Any
references made by either company mentioned in this press release regarding
forward-looking public statements concerning expected future financial
position, results of operations, cash flows, financing plans, business
strategy, products and services, competitive positions, growth opportunities,
plans and objectives of management for future operations, including statements
that include words such as "anticipate," "if,"
"believe," "plan," "estimate,"
"expect," "project", "intend," "may,"
"could," "should," "will," and other similar
expressions are forward-looking statements, including but not limited to: that
any additional patent protection will be realized or that patent achievements
will deliver material results. Such forward-looking statements are estimates
reflecting either company's best judgment based upon current information and
involve a number of risks and uncertainties, and there can be no assurance that
other factors will not affect the accuracy of such forward-looking statements.
Factors which could cause actual results to differ materially from those
estimated by either company include, but are not limited to, government regulation
and regulatory approvals, managing and maintaining growth, the effect of
adverse publicity, litigation, competition, scientific discovery, the patent
application and approval process and other factors which may be identified from
time to time in either company's public announcements and filings. There is no
assurance that existing capital is sufficient for either company's needs or
that either company will be able to raise additional capital. There is no
assurance that either company will be capable of developing, marketing,
licensing, or selling edible products containing cannabinoids, nicotine or any
other active ingredient. There is no assurance that any planned corporate
activity, scientific research or study, business venture, letter of intent,
technology licensing pursuit, patent application or allowance, consumer study,
or any initiative will be pursued, or if pursued, will be successful. There is
no assurance that any of either company's postulated uses, benefits, or
advantages for patented, patent-pending technology or unpatented processes will
in fact be realized in any manner or in any part. No statement herein has been
evaluated by the Food and Drug Administration (FDA). Neither company's
products are intended to diagnose, treat, cure or prevent any disease.
Neither TSX Venture Exchange nor its Regulation
Services Provider (as that term is defined in policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE Hill Street Beverage Company Inc.
For further information: Press only: Terry Donnelly,
Chairman and CEO, Hill Street Beverage Company Inc., terry@hillstreetbevco.com, (416) 543-4904; For investors: Gareth Tingling,
Investor Relations, gareth@sophiccapital.com, (647) 797-0219; Lexaria Bioscience Corp., Alex Blanchard,
Communications Manager, (778) 796-1897,
Investorideas.com
potcasts - cannabis news and stocks to watch plus insight from thought
leaders and experts is
sponsored by Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)
Disclaimer/Disclosure: Investorideas.com is
a digital publisher of third party sourced news, articles and equity research
as well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and followers.
More disclaimer and disclosure info: http://www.investorideas.com/About/Disclaimer.asp. For disclosure purposes Lexaria Bioscience Corp is a paid
client on Investorideas as a sponsor of the daily potcast http://www.investorideas.com/About/News/Clientspecifics.asp
Additional info regarding BC Residents and global Investors:
Effective September 15 2008 - all BC investors should review all OTC and Pink
sheet listed companies for adherence in new disclosure filings and filing
appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.
Global investors must adhere to regulations of each country.
Monday, July 30, 2018
Investorideas.com - #Cannabis Industry to Benefit From Fresh Innovation as BIG Industry Show Heads to Los Angeles This August 30-31
Investorideas.com - #Cannabis Industry to Benefit From Fresh Innovation as BIG Industry Show Heads to Los Angeles This August 30-31
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: TSXV: $OGI.V, TSX: $ACB.TO, TSXV: $ALEF.V, TSXV: $EMH.V
Investor Ideas #Potcasts #Cannabis News
and Stocks on the Move: TSXV: $OGI.V,
TSX: $ACB.TO, TSXV: $ALEF.V, TSXV: $EMH.V
July 30th Potcast
sponsored by Lexaria Bioscience Corp. ( CSE: $LXX.C ) (OTC: $LXRP) a #Cannabis
company with a new disruptive drug delivery platform: DehydraTECH
Delta, Kelowna, BC –July 30, 2018 (Investorideas.com
Newswire) www.Investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks and its “potcast’ site, www.potcasts.ca release today’s edition of its series, Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at http://www.investorideas.com/news/2018/cannabis/07303Potcasts-TSXV-OGI-ACB-ALEF-EMH.asp
Today’s podcast overview/transcript:
Good morning and welcome to another Investorideas.com potcast – looking
at cannabis news, stocks to watch as well as insights from thought leaders and
experts.
Today’s potcast was sponsored by Kelowna based Lexaria Bioscience Corp trading on the CSE under symbol LXX and on
the OTC as LXRP. Lexaria has developed a new disruptive
drug delivery platform: DehydraTECH The Company’s patented technology changes
the way Active Pharmaceutical Ingredients (“APIs”) enter the body orally:
1) Masks unwanted tastes – eliminates the need for sugar-filled edibles.
2) Reduces time of onset – effects are felt within 15-20 min vs. 60-120
min.
3) Avoids first-pass liver metabolism
4) Increases bio-absorption by 5-10X
The Company’s DehydraTECH™ technology is patent-protected for multiple
APIs: Cannabidiol (CBD), Tetrahydrocannabinol (THC), Non-steroidal
anti-inflammatory drugs (NSAIDs) such as ibuprofen, Nicotine and Fat soluble
vitamins.
Today’s podcast features news from Organigram Holdings Inc( TSX-VENTURE: OGI and OTCQB: OGRMF), Aurora Cannabis Inc. (TSX: ACB and OTCQB: ACBFF), Aleafia Health Inc. (TSX-VENTURE: ALEF) , Emerald Health
Therapeutics, Inc. (TSX-VENTURE: EMH) and Village Farms
International, Inc. (TSX : VFF and OTC: VFFIF) .
Organigram Holdings Inc., the parent company of Organigram Inc., a
leading licensed producer of medical marijuana based in Moncton, New Brunswick,
announced its financial results for the three and nine-months ended May 31,
2018.
Some of the operational highlights include:
·
Organigram began harvesting from its Phase 2 expansion facility (23 grow
rooms) on April 20, 2018 bringing its target production of dried flower
equivalent to 22,000 kg/annum;
·
In May the Company launched its adult recreational brand strategy which
included house brands such as The
Edison Cannabis Company, ANKR
Organics and Trailer
Park Buds;
·
In May Organigram received a "License for Controlled Drugs and
Substances" from Health Canada making the Company a Licensed Dealer;
·
In May the Company received its "Permit to Export Cannabis"
license which allowed Organigram the ability to make its first international
medical shipment to Australia (completed in July);
·
Shortly after quarter-end the Company began use of its Phase 3 expansion
filling six of the 16 grow rooms with the remaining rooms filled in June and
July bringing its target production of dried flower equivalent to 36,000
kg/annum; and
·
Announced strategic investments in: Hyasynth Biologicals, Alpha-Cannabis
Germany, and Eviana (see previous press releases for more details) which all
are expected to close in the calendar third quarter.
Some of the financial highlights included:
·
Record net sales for both the three-months and nine-months ended May 31,
2018 of $3.7 million and $10.1 million respectively vs. $1.9 million and $3.6
million respectively for 2017;
·
Record sale volume of cannabis oil for the three-months ended May 31,
2018 (768,400 milliliters) up 39% from Q2/18 (552,250) and up 452% from Q3/17
(139,200 milliliters);
·
Record sales volume of dried flower (303,428 grams) for the three-months
ended up 28% from Q2/18 (237,650 grams) and up 55% from Q3/17 (196,129 grams);
·
Record yields per plant in the quarter ended May 31, 2018 (see MD&A
for further details);
·
Cost of cultivation per gram of dried flower harvested of $0.80 per gram
"all-in" (direct labour and materials, allocated overhead and
depreciation) and $0.58/gram excluding depreciation. Note that cost of
cultivation is a non-GAAP measure used by management internally and does not
include indirect production, packaging or shipping costs (see financial
statements and MD&A for further details);
·
Registered medical patients climbed to a record 15,316 by the end of Q3
up 18% since Q2 (12,957);
·
Impairment of goodwill on its 2017 acquisition of Trauma Healing Centres
in the amount of $1.2 million related to "right sizing" of the
business opportunity;
·
Net interest expense of $3.7 million for the quarter primarily
attributable to the interest expense on $115 million of convertible debentures
issued on January 31, 2018; and
·
Net income of $2.8 million, an increase of 162% compared to $1.1 million
in Q2-2018 and a loss of $2.3 million in Q3-2017.
Aurora Cannabis Inc. today announced that it has
obtained a Health Canada Dealer's License ("Dealer's License") under
the Controlled Drugs and Substances
Act for its EU GMP certified Aurora Mountain facility in Alberta. The
new license will allow Aurora additional opportunities to produce, assemble,
and sell cannabis oils and future novel, derivative products from Aurora
Mountain, Furthermore, the license provides additional opportunities to
transport cannabis products for import from and export to international
markets, subject to applicable regulations.
A dealer's license is also critical for expanding research and
development capacity as it provides the potential for working with cannabinoids
and their derivatives not covered under an ACMPR license. This will enable
Aurora and its subsidiaries to drive innovation in the form of marketable
intellectual property, and new value-added products.
Aleafia Health Inc., one of Canada's leading, vertically
integrated medical cannabis companies with a unique patient-focused, healthcare
solution, announced that it has closed its previously announced acquisition of
a modern, fully automated 160,000 sq. ft. greenhouse in the Niagara Region.
Renovations at the facility are already underway, with the facility
expected to be retrofitted and licensed before the end of 2018, with a first
harvest expected in spring 2019. The facility will join Aleafia's existing
licenced facility in Scugog, Ontario, which is expected to undergo a 150,000
sq. ft. expansion.
Emerald Health Therapeutics, Inc. and Village Farms International, Inc.
today announced that their 50/50 joint venture for large-scale, low-cost,
high-quality cannabis production, Pure Sunfarms, has received its cannabis
sales license from Health Canada. Pure Sunfarms is now permitted to immediately
begin selling product from its expanding inventory of high-quality dried
cannabis, including to Emerald Health Therapeutics, under their previously
announced supply agreement, as well as to address significant demand from other
licensed producers. This sales license also positions Pure Sunfarms to secure
supply agreements with provincial government distributors for the imminent legal
adult-use marketplace.
Investor ideas reminds
all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy
products or services or securities. Investors are reminded all investment
involves risk and possible loss of investment
Lexaria Bioscience Corp. has developed and
out-licenses its disruptive delivery technology that promotes healthier
ingestion methods, lower overall dosing and higher effectiveness of lipophilic
active molecules. Lexaria has multiple patents pending in over 40 countries
around the world and has patents granted in the USA and in Australia for
utilization of its DehydraTECHTM delivery technology. Lexaria's technology
provides increases in intestinal absorption rates; more rapid delivery to the
bloodstream; and important taste-masking benefits, for orally administered
bioactive molecules including cannabinoids, vitamins, non-steroidal
anti-inflammatory drugs (NSAIDs), nicotine and other molecules. www.lexariabioscience.com
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on
iTunes, Spotify, Google Play Music,
Stitcher iHeartradio and Tunein.
Potcasts is now a certified word
mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires
Big Ideas
Investorideas.com is
a meeting place for global investors, featuring news, stock directories, video,
company profiles, interviews and more in leading sectors.
Investorideas.com
cannabis/marijuana and hemp content now includes http://cannabisstocknews.blogspot.com on Blogger.com: the Investorideas.com news and stock
directory pages, a cannabis investor group on Linkedin.com , the 420 Cannabis
Investor ideas www.420cannabisinvestorideas.com, and the new AI site Global Cannabis Investing at www.Globalcannabisinvesting.com
Disclaimer/Disclosure: Investorideas.com is
a digital publisher of third party sourced news, articles and equity research
as well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. Disclosure Lexaria
Bioscience Corp. ( CSE: LXX) (OTC: LXRP) is a media sponsor of the podcast
starting July 5 2018 more info http://www.investorideas.com/About/News/Clientspecifics.asp
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with Sedar.
Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations
of each country.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
Do you trade or invest in Marijuana / Hemp Stocks? Check out our stock directory of publicly
traded CSE, TSX, TSXV, OTC, NASDAQ,
NYSE, ASX Marijuana / Hemp Stocks
Join our Group on Linkedin and talk about - Marijuana / Hemp Stocks - News and Trends in Green Investing
Friday, July 27, 2018
InvestorIdeas & Stock Analyst Guru - Support and Resistance Trading Ep4 ...
www.investorideas.com - News that inspires big Ideas
Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: TSXV: AB...
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Investorideas.com - #Cannabisstocks: Canada Coal (TSX-V:CCK) Announces Proposed Reverse Takeover Transaction of Medcolcanna S.A.S.
Investorideas.com - #Cannabisstocks: Canada Coal (TSX-V:CCK) Announces Proposed Reverse Takeover Transaction of Medcolcanna S.A.S.
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: TSXV: $ABCN.V, TSXV: $PURE.V, CSE: $MDM.C
Investor Ideas #Potcasts #Cannabis News
and Stocks on the Move: TSXV: $ABCN.V,
TSXV: $PURE.V, CSE: $MDM.C
July 27th Potcast
sponsored by Lexaria Bioscience Corp. ( CSE: $LXX.C ) (OTC: $LXRP) a #Cannabis
company with a new disruptive drug delivery platform: DehydraTECH
Delta, Kelowna, BC –July 27, 2018 (Investorideas.com
Newswire) www.Investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks and its “potcast’ site, www.potcasts.ca release today’s edition of its series, Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at http://www.investorideas.com/news/2018/cannabis/07272Potcasts-TSXV-ABCN-PURE-CSE-MDM.asp
Today’s podcast overview/transcript:
Good morning and welcome to another Investorideas.com potcast – looking
at cannabis news, stocks to watch as well as insights from thought leaders and
experts.
Today’s potcast was sponsored by Kelowna based Lexaria Bioscience Corp trading on the CSE under symbol LXX and on
the OTC as LXRP. Lexaria has developed a new disruptive
drug delivery platform: DehydraTECH The Company’s patented technology changes
the way Active Pharmaceutical Ingredients (“APIs”) enter the body orally:
1) Masks unwanted tastes – eliminates the need for sugar-filled edibles.
2) Reduces time of onset – effects are felt within 15-20 min vs. 60-120
min.
3) Avoids first-pass liver metabolism
4) Increases bio-absorption by 5-10X
The Company’s DehydraTECH™ technology is patent-protected for multiple
APIs: Cannabidiol (CBD), Tetrahydrocannabinol (THC), Non-steroidal
anti-inflammatory drugs (NSAIDs) such as ibuprofen, Nicotine and Fat soluble
vitamins.
Today’s podcast features news from ABcann
Global Corporation (TSX-Venture: ABCN) , Pure Global Cannabis Inc. (TSX-Venture :PURE and OTC : PRCNF) and Marapharm Ventures Inc. (CSE : MDM) .
ABcann Global Corporation announced the introduction
of FIRESIDE, its first recreational cannabis brand.
“Legalization will bring a wide variety of different consumers to
cannabis, and many will want a high-quality product without having to be an
expert at choosing between strains. That’s why we created FIRESIDE – it’s
a premium brand for those who want great products that are easy to understand.
To ensure a superior quality experience, FIRESIDE cannabis will be grown in
small batches in craft-like conditions,” says Sung Kang, Chief Marketing
Officer. “As well, our special long-curing process means a smoother final
product.”
FIRESIDE has been tailored specifically for social cannabis users, based
on extensive research and consumer insights. When the adult-use recreational
cannabis market opens to Canadians on October 17, 2018, FIRESIDE products will
be available in both dried whole-bud and pre-rolled formats.
FIRESIDE epitomizes the social experience of sharing good times with
friends around a fire, whether at the cabin or in an urban setting. Crafted for
social occasions, FIRESIDE will appeal to the premium segment of the adult-use
recreational cannabis market.
Pure Global Cannabis Inc. announced that its wholly-owned subsidiary,
PureSinse Inc. has signed definitive Supply Agreements with The Supreme
Cannabis Company, Inc. ("Supreme") (TSXV: FIRE) and two other
reputable Access to Cannabis for
Medical Purposes Regulations ("ACMPR") Licensed Producers,
from whom PureSinse has purchased various quantities of premium quality medical
cannabis that meet the high-quality standard requirements of PURE.
These Agreements represent a significant milestone for PureSinse, as it
has now received the necessary product required to obtain a Sales License under
the ACMPR which is expected in Q3 2018.
Marapharm Ventures Inc. announced on June 1, 2018, that cloning had
begun in preparation for the transition to the permanent facilities.
Kurt Keating, Director of Operations, reports that several hundred
clones have taken root over the past eight weeks in our transitional buildings
and are exhibiting vigorous growth. "Our
Cultivators are in the process of a secondary 'cutting' of clones to commence a
perpetual harvest schedule. We remain on track and do not anticipate delays to
our production schedule."
Investor ideas reminds
all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy
products or services or securities. Investors are reminded all investment
involves risk and possible loss of investment
Lexaria Bioscience Corp. has developed and
out-licenses its disruptive delivery technology that promotes healthier
ingestion methods, lower overall dosing and higher effectiveness of lipophilic
active molecules. Lexaria has multiple patents pending in over 40 countries
around the world and has patents granted in the USA and in Australia for
utilization of its DehydraTECHTM delivery technology. Lexaria's technology
provides increases in intestinal absorption rates; more rapid delivery to the
bloodstream; and important taste-masking benefits, for orally administered
bioactive molecules including cannabinoids, vitamins, non-steroidal
anti-inflammatory drugs (NSAIDs), nicotine and other molecules. www.lexariabioscience.com
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on
iTunes, Spotify, Google Play Music,
Stitcher iHeartradio and Tunein.
Potcasts is now a certified word
mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires
Big Ideas
Investorideas.com is
a meeting place for global investors, featuring news, stock directories, video,
company profiles, interviews and more in leading sectors.
Investorideas.com
cannabis/marijuana and hemp content now includes http://cannabisstocknews.blogspot.com on Blogger.com: the
Investorideas.com news and stock directory pages, a cannabis investor group on
Linkedin.com , the 420 Cannabis Investor ideas www.420cannabisinvestorideas.com, and the new AI site Global Cannabis Investing at www.Globalcannabisinvesting.com
Disclaimer/Disclosure: Investorideas.com is
a digital publisher of third party sourced news, articles and equity research
as well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. Disclosure Lexaria
Bioscience Corp. ( CSE: LXX) (OTC: LXRP) is a media sponsor of the podcast
starting July 5 2018 more info http://www.investorideas.com/About/News/Clientspecifics.asp
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations
of each country.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
Do you trade or invest in Marijuana / Hemp
Stocks? Check out our stock directory of
publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX
Marijuana / Hemp Stocks
Join our Group on Linkedin and talk about - Marijuana / Hemp Stocks - News and Trends in Green Investing
Subscribe to:
Posts (Atom)